InvestorsHub Logo

justdafactss

06/16/22 10:09 AM

#210643 RE: moneycrew #210642

CYDY is turning out to be a suckers bet even for execs.

What other publicly traded bio pays exec salary in shares?

ClosetInvestor

06/16/22 10:15 AM

#210644 RE: moneycrew #210642

“Laughing- you think these execs would take stock in lieu of cash if they knew Cytodyn was in trouble?”

They may not have a choice with looming Samsung debt, the Welch loan they have to pay off, trial costs, legal costs and day to day operations.